Summary
For Year 2026-27, Mahamaya Lifesciences reports the following shareholding: Total Promoters at 56.35%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 4.77%, Domestic Institutional Investors at 2.52%, and Retail at 36.36%. This breakdown provides a quick snapshot of ownership distribution for Mahamaya Lifesciences in 2026-27.
Mahamaya Lifesciences FAQs
As of 04-2026, the promoter shareholding in Mahamaya Lifesciences stands at 56.35% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Mahamaya Lifesciences is 4.77% and 2.52% respectively.
The retail shareholding of the Mahamaya Lifesciences is 36.36%.
Changes in shareholding patterns of Mahamaya Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Mahamaya Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Mahamaya Lifesciences Associated Pages
